Peter Keith

Entellus Medical, Inc. is a medical technology company, which engages in the design, development, and commercialization of treatment of chronic and recurrent sinusitis in both adult and pediatric patients. The company was founded by Thomas V. Ressemann and Peter Keith in April 2006 and is headquartered in Saint Paul, MN.

Part of Cardinal Health, Inc., TERAMed, Inc. designs, develops, and manufactures endovascular graft systems. The company is based in Maple Grove, MN. TERAMed was acquired by Cordis Corp., part of Cardinal Health, Inc. from October 04, 2015 on December 18, 2001.

Myocor, Inc. develops products for the treatment of mitral regurgitation and congestive heart failure. It has two products in clinical trials that are designed to improve the pumping efficiency of the heart and thus improve the quality of life of patients. The company was founded in 1996 by Cyril J. Schweich and Todd Mortier and is headquartered in Maple Grove, MN.

CoAxiaTM was a development stage, private, venture-backed medical device company in clinical trials with an innovative, catheter-based therapy for the treatment of cerebral ischemia, most notably: ischemic stroke. CoAxia's business focus was demonstrating the safety and efficacy of its NeuroFlo™ catheter and making it a standard treatment option hundreds of thousands of stroke patients worldwide. In addition, CoAxia was in limited distribution of NeuroFlo to treat cerebral vasospasm, under an HDE market approval from the FDA. CoAxia holds several key patents on the concept and implementation of cerebral perfusion augmentation as well as numerous other patents relevant to various vascular disorders. CoAxia was founded in 1999 by Denise Barbut MD.

Velocimed LLC develops, manufactures, and markets medical devices. The firm's products are used in cardiology and neurology applications. The company was founded in 2001 by Jay Schmelter, Michael Berman, and Dennis W. Wahr and is headquartered in Maple Grove, MN.